Updated:
CTI Life Sciences
CTI Life Sciences is a biotech venture capital firm and company builder that catalyzes nascent ideas and assets into investable, scalable, and marketable...
Overview
CTI Life Sciences is a biotech venture capital firm and company builder that catalyzes nascent ideas and assets into investable, scalable, and marketable biotech companies. It pursues transformative investments in the biotech industry with a therapeutic and modality agnostic approach. The firm reports 20+ years in business, 30+ investments, multiple funds raised, and a dual-pronged strategy focused on long-term value creation and expedited exits.
General information
Firm type
Private Equity
Year founded
2006
Location
Region
North America
Country
Canada
City
Montreal
Corporate office
Montreal, Canada
Principals
Ken Pastor
Managing Partner (Founding General Partner)
Laurence Rulleau
Managing Partner
Youssef Bennani
Managing Partner
Shermaine Tilley
Managing Partner
Dana Matzen
Partner
Xin Hang
Senior Principal
Sector focus
Frequently asked questions
What investment stages does CTI Life Sciences target?
The firm covers early-stage seed, start-up, expansion, and late-stage venture opportunities.
Does CTI Life Sciences participate in fund commitments or only direct deals?
Available information does not specify fund commitments versus direct investments.
Which sectors does CTI Life Sciences focus on?
The firm concentrates on life sciences investments.
Where is CTI Life Sciences headquartered?
The firm is based in Montreal, Canada.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: